Related Experiment Video
Updated: Jul 26, 2026

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Survival differences in pulmonary metastatic osteosarcoma between pediatric and adult institutions
Daniel R Liesman1, William J Kacey1, Kelly R Bates1
1Department of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital, Northwestern University, Chicago, IL, USA.
Insights
Patients with relapsed osteosarcoma and lung metastases treated at pediatric hospitals showed improved survival. Further studies are needed to identify specific treatment factors influencing outcomes in osteosarcoma patients.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Osteosarcoma with pulmonary metastases has a poor prognosis.
- Pediatric surgeons may use more aggressive treatments than adult surgeons for metastatic osteosarcoma.
- The impact of institutional care setting on survival for relapsed osteosarcoma is unclear.
Purpose of the Study:
- To test the hypothesis that pediatric patients with relapsed pulmonary metastatic osteosarcoma treated at pediatric institutions have improved survival compared to those treated at adult institutions.
- To explore differences in treatment approaches between pediatric and adult institutions for relapsed osteosarcoma.
Main Methods:
- Retrospective chart review of adult and pediatric patients with relapsed pulmonary osteosarcoma.
- Exclusion of adult patients over 60 to minimize comorbidity effects.
- Survival analysis using Kaplan-Meier estimates and Cox regression models.
Main Results:
- 28 pediatric and 24 adult patients were included.
- Pediatric patients more frequently had extremity tumors (82% vs. 46%).
- Care at a pediatric institution was associated with improved overall survival on univariable analysis (HR 0.48; P=0.028), but not independently predictive on multivariable analysis.
Conclusions:
- Patients treated at pediatric institutions demonstrated improved survival after pulmonary relapse of osteosarcoma.
- While institutional care alone was not independently predictive, findings support further multi-institutional research.
- Identifying modifiable factors influencing outcomes in relapsed osteosarcoma is crucial.
Purpose:
Prognosis for osteosarcoma with pulmonary metastases remains poor at all ages. Pediatric surgeons often employ a more aggressive approach to surgical disease clearance compared to adult surgeons, but the survival impact is unclear. We hypothesized that patients with relapsed pulmonary metastatic osteosarcoma cared for at pediatric institutions will show improved survival compared to patients cared for at adult institutions reflecting differences in treatment approach.
Methods:
A retrospective chart review was performed at affiliated free-standing adult and pediatric hospitals. Characteristics were recorded of adult and pediatric patients with pulmonary relapse of osteosarcoma following primary tumor treatment. Adults over 60-years-of-age were excluded to minimize the effect of medical comorbidities. Overall survival was analyzed with Kaplan-Meier estimates and univariable and multivariable Cox regression.
Results:
There were 28 pediatric and 24 adult patients. A greater number of pediatric patients had extremity tumors (82 % versus 46 %; p-value = 0.006). Timing of relapse was similar between groups. Care at a pediatric institution was associated with improved overall survival on univariable analysis (Hazard Ratio for mortality 0.48 [0.25, 0.92]; p-value = 0.028). Extremity tumor location, favorable response to neoadjuvant chemotherapy, and greater number of thoracic surgeries were also associated with improved survival. However, on multivariable analysis adjusting for favorable initial response and primary tumor site, institution was not independently predictive of survival.
Conclusions:
Patients treated at pediatric institutions had improved survival following pulmonary relapse. While institution alone was not independently predictive after adjustment in this cohort, these findings support further multi-institutional studies to identify modifiable factors that may influence outcomes.
More Related Videos
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

